Insuman Comb 30

Insulin human, the active ingredient in Insuman Comb 30, is an insulin presented as a premixed insulin 30 formulation for subcutaneous use. It treats hyperglycemia in type 1 and type 2 diabetes mellitus, offering both rapid‑acting and intermediate‑acting components to cover mealtime and basal glucose needs.

GNH USA supplies Insuman Comb 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 30 is used in the insulin pathway to manage blood glucose in diabetes mellitus.

- Type 1 diabetes mellitus: provides basal and prandial insulin coverage to lower blood glucose levels. - Type 2 diabetes mellitus: assists in achieving glycaemic control when oral agents are insufficient. - Hyperglycemia: reduces elevated plasma glucose concentrations.

Insuman Comb 30 may be associated with several adverse reactions, which are categorized by frequency.

Common Side Effects: - Hypoglycaemia: episodes of low blood glucose, especially if meals are missed or activity is increased. - Injection‑site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase in body weight due to improved glucose utilization. - Lipodystrophy: localized thickening or loss of subcutaneous fat with repeated injections. - Mild allergic response: urticaria or localized rash.

Serious or Rare Side Effects: - Severe hypoglycaemia: profound low glucose requiring assistance. - Anaphylactic reaction: systemic allergic response that can be life‑threatening. - Edema: fluid accumulation, particularly in the lower extremities. - Insulin antibody formation: may alter insulin effectiveness. - Hypokalemia: low potassium levels in rare cases.

When using Insuman Comb 30, several precautions should be observed to ensure safe therapy.

- Dose adjustment: tailor the regimen based on regular blood glucose monitoring and individual response. - Renal impairment: monitor closely as reduced clearance may increase hypoglycaemia risk. - Elderly patients: start with lower doses and titrate slowly to avoid sudden glucose drops. - Pregnancy and lactation: use only if the expected benefit outweighs potential risk; consult a specialist. - Alcohol consumption: may mask hypoglycaemia symptoms and potentiate low glucose events. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 30 can interact with other medicines, influencing glucose control or insulin action.

Major Interactions (Avoid): - Beta‑blockers: may conceal hypoglycaemia warning signs. - MAO inhibitors: unpredictable alterations in blood glucose levels. - Alcohol (excessive): can potentiate insulin‑induced hypoglycaemia.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may raise blood glucose concentrations. - Corticosteroids: can increase insulin resistance, requiring dose adjustments. - Oral hypoglycaemic agents (e.g., sulfonylureas): additive glucose‑lowering effect, increasing hypoglycaemia risk.